Comparison of Platelet Rich Fibrin, Platelet Rich Plasma and mineral trioxide aggregate as pulpotomy agents in primary mandibular molars

Comparative evaluation of Platelet Rich Plasma, Platelet Rich Fibrin and Mineral Trioxide Aggregate as pulpotomy agents in primary molars - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068937

Enrollment

Registered

2024-06-14

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K040- Pulpitis

Interventions

Intervention1: Platelet RichFibrin, Platelet Rich Plasma: Pulpotomy on Patient will be done with Platelet Rich Fibrin and Platelet Rich Plasma and will be followed up for a period of 9 months Control

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy children in age group of 4-8years. 2. Patient compliance with treatment. 3. No spontaneous or nocturnal pain and tenderness to percussion. 4. Caries removal results in pulp exposure with normal pulp or reversible pulpitis. 5. Ease of hemorrhage control post access-opening and excavation from amputated pulp stumps.

Exclusion criteria

Exclusion criteria: 1. Existence of spontaneous pain or nocturnal pain, with clinical signs or symptoms of pulp degeneration (swelling, abscess, fistula, pathologic mobility). 2. Caries penetrating the floor of pulp chamber. 3. Radiographic evidence of teeth with internal resorption. 4. Teeth with physiologic resorption of root not more than one third with restorable remaining tissue. 5. Presence of inter-radicular bone loss. 6. Tooth close to natural exfoliation. 7. Teeth with developmental defects. 8. Children with special health care needs

Design outcomes

Primary

Measure	Time frame
To evaluate Clinical comparison of Platelet Rich Plasma, Platelet Rich Fibrin and mineral trioxide aggregate as a pulpotomy agents in primary molarsTimepoint: Over a period of 3,6 and 9 months	—

Secondary

Measure	Time frame
To evaluate Radiographic comparison of Platelet Rich Plasma, Platelet Rich Fibrin and mineral trioxide aggregate as a pulpotomy agents in primary molarsTimepoint: Over a period of 3,6 and 9 months	—

Countries

India

Contacts

Public ContactDr Aman Kumar

UCMS & GTBH Dilshad Garden Delhi 110095

tyagi_rishidoc@hotmail.com986857552

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026